Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alain Sarasin

Showing results (1-10 of 137) with videos related to

Pageof 14
Sort By:
Genome Medicine|May 25, 2012
UVSSA and USP7: new players regulating transcription-coupled nucleotide excision repair in human cellsAlain Sarasin
Advances in Experimental Medicine and Biology|February 3, 2009
Progress and prospects of xeroderma pigmentosum therapyAlain Sarasin
DNA Repair|February 28, 2003
Choice between death by senescence or by cancer?Alain Sarasin
Mutation Research|December 4, 2003
An overview of the mechanisms of mutagenesis and carcinogenesisAlain Sarasin
DNA Repair|June 10, 2026
DNA-repair and transcriptional defects drive hematologic malignancies in xeroderma pigmentosum group C patients: A new hypothesisAlain Sarasin
Cancers|June 22, 2023
The French Cohort of DNA Repair-Deficient Xeroderma Pigmentosum Patients: Risk of Hematological MalignanciesAlain Sarasin
Cells, Tissues, Organs|September 25, 2004
Xeroderma pigmentosum: from symptoms and genetics to gene-based skin therapyThierry Magnaldo, Alain Sarasin
DNA Repair|December 30, 2006
New insights for understanding the transcription-coupled repair pathwayAlain Sarasin, Anne Stary
Mutagenesis|November 19, 2002
ERCC2/XPD gene polymorphisms and cancer riskSimone Benhamou, Alain Sarasin
Mutation Research|May 27, 2005
Hypothetical role of RNA damage avoidance in preventing human diseaseDamien Brégeon, Alain Sarasin
Pageof 14

Showing results (1-10 of 137) with videos related to

Sort By:
Pageof 14
Genome Medicine|May 25, 2012
UVSSA and USP7: new players regulating transcription-coupled nucleotide excision repair in human cellsAlain Sarasin
Advances in Experimental Medicine and Biology|February 3, 2009
Progress and prospects of xeroderma pigmentosum therapyAlain Sarasin
DNA Repair|February 28, 2003
Choice between death by senescence or by cancer?Alain Sarasin
Mutation Research|December 4, 2003
An overview of the mechanisms of mutagenesis and carcinogenesisAlain Sarasin
DNA Repair|June 10, 2026
DNA-repair and transcriptional defects drive hematologic malignancies in xeroderma pigmentosum group C patients: A new hypothesisAlain Sarasin
Cancers|June 22, 2023
The French Cohort of DNA Repair-Deficient Xeroderma Pigmentosum Patients: Risk of Hematological MalignanciesAlain Sarasin
Cells, Tissues, Organs|September 25, 2004
Xeroderma pigmentosum: from symptoms and genetics to gene-based skin therapyThierry Magnaldo, Alain Sarasin
DNA Repair|December 30, 2006
New insights for understanding the transcription-coupled repair pathwayAlain Sarasin, Anne Stary
Mutagenesis|November 19, 2002
ERCC2/XPD gene polymorphisms and cancer riskSimone Benhamou, Alain Sarasin
Mutation Research|May 27, 2005
Hypothetical role of RNA damage avoidance in preventing human diseaseDamien Brégeon, Alain Sarasin
Pageof 14